Epitol

Chronic Pain, Bipolar Disorder, Bipolar Disorder + 6 more

Treatment

15 FDA approvals

20 Active Studies for Epitol

What is Epitol

Carbamazepine

The Generic name of this drug

Treatment Summary

Carbamazepine, also called Tegretol, is a medication used to prevent seizures and reduce the pain of trigeminal neuralgia. It was approved by the FDA in 1965 and is also given to treat bipolar disorder. This drug was the first anticonvulsant specifically developed for bipolar disorder.

Tegretol

is the brand name

Epitol Overview & Background

Brand Name

Generic Name

First FDA Approval

How many FDA approvals?

Tegretol

Carbamazepine

1968

259

Approved as Treatment by the FDA

Carbamazepine, commonly known as Tegretol, is approved by the FDA for 15 uses like Partial Seizures With Secondary Generalization and Bipolar Disorder .

Partial Seizures With Secondary Generalization

Bipolar Disorder

Bipolar Disorder

Pain

Helps manage Pain

Common Cold

Trigeminal Neuralgia

Helps manage Trigeminal Neuralgia (TN)

Generalized Tonic-Clonic Seizures

Chronic Pain

Helps manage Pain

Bipolar 1 Disorder

Mixed manic depressive episode

Acute Mania

Trigeminal Neuralgia (TN)

Helps manage Trigeminal Neuralgia (TN)

Partial-Onset Seizures

Seizures

Seizures

Effectiveness

How Epitol Affects Patients

Carbamazepine is a drug used to treat seizures and facial nerve pain. It also has been found to reduce symptoms of mania in people with bipolar disorder. The effects of carbamazepine are specific to the person, and it is important to pay attention to genetic variations as people with a certain gene type (HLA-B*1502) have been found to have a greater risk of serious skin reactions from taking this drug.

How Epitol works in the body

Carbamazepine works by inhibiting the activity of certain nerve cells and decreasing the pain response to nerve stimulation. It is believed to treat seizure activity and bipolar disorder by increasing dopamine turnover and GABA transmission. However, some people can develop resistance to carbamazepine, which may be due to a variant gene. Recently, a gene promoter has been identified as a potential target to reduce this resistance.

When to interrupt dosage

The proposed dosage of Epitol is contingent upon the determined affliction, including Partial Seizures With Secondary Generalization, Bipolar Disorder and Trigeminal Neuralgia. The measure of dosage is contingent upon the method of delivery as specified in the table underneath.

Condition

Dosage

Administration

Common Cold

, 100.0 mg, 200.0 mg, 400.0 mg, 300.0 mg, 100.0 mg/mL, 20.0 mg/mL, 10.0 mg/mL

, Tablet, extended release - Oral, Tablet, extended release, Oral, Suspension - Oral, Suspension, Capsule, extended release - Oral, Tablet - Oral, Tablet, Capsule, extended release, Injection, powder, for solution, Intravenous, Injection, powder, for solution - Intravenous, Tablet, chewable, Tablet, chewable - Oral, Solution, Solution - Oral

Trigeminal Neuralgia

, 100.0 mg, 200.0 mg, 400.0 mg, 300.0 mg, 100.0 mg/mL, 20.0 mg/mL, 10.0 mg/mL

, Tablet, extended release - Oral, Tablet, extended release, Oral, Suspension - Oral, Suspension, Capsule, extended release - Oral, Tablet - Oral, Tablet, Capsule, extended release, Injection, powder, for solution, Intravenous, Injection, powder, for solution - Intravenous, Tablet, chewable, Tablet, chewable - Oral, Solution, Solution - Oral

Seizures

, 100.0 mg, 200.0 mg, 400.0 mg, 300.0 mg, 100.0 mg/mL, 20.0 mg/mL, 10.0 mg/mL

, Tablet, extended release - Oral, Tablet, extended release, Oral, Suspension - Oral, Suspension, Capsule, extended release - Oral, Tablet - Oral, Tablet, Capsule, extended release, Injection, powder, for solution, Intravenous, Injection, powder, for solution - Intravenous, Tablet, chewable, Tablet, chewable - Oral, Solution, Solution - Oral

Syndrome

, 100.0 mg, 200.0 mg, 400.0 mg, 300.0 mg, 100.0 mg/mL, 20.0 mg/mL, 10.0 mg/mL

, Tablet, extended release - Oral, Tablet, extended release, Oral, Suspension - Oral, Suspension, Capsule, extended release - Oral, Tablet - Oral, Tablet, Capsule, extended release, Injection, powder, for solution, Intravenous, Injection, powder, for solution - Intravenous, Tablet, chewable, Tablet, chewable - Oral, Solution, Solution - Oral

Restless Legs Syndrome

, 100.0 mg, 200.0 mg, 400.0 mg, 300.0 mg, 100.0 mg/mL, 20.0 mg/mL, 10.0 mg/mL

, Tablet, extended release - Oral, Tablet, extended release, Oral, Suspension - Oral, Suspension, Capsule, extended release - Oral, Tablet - Oral, Tablet, Capsule, extended release, Injection, powder, for solution, Intravenous, Injection, powder, for solution - Intravenous, Tablet, chewable, Tablet, chewable - Oral, Solution, Solution - Oral

Bipolar Disorder

, 100.0 mg, 200.0 mg, 400.0 mg, 300.0 mg, 100.0 mg/mL, 20.0 mg/mL, 10.0 mg/mL

, Tablet, extended release - Oral, Tablet, extended release, Oral, Suspension - Oral, Suspension, Capsule, extended release - Oral, Tablet - Oral, Tablet, Capsule, extended release, Injection, powder, for solution, Intravenous, Injection, powder, for solution - Intravenous, Tablet, chewable, Tablet, chewable - Oral, Solution, Solution - Oral

Chronic Pain

, 100.0 mg, 200.0 mg, 400.0 mg, 300.0 mg, 100.0 mg/mL, 20.0 mg/mL, 10.0 mg/mL

, Tablet, extended release - Oral, Tablet, extended release, Oral, Suspension - Oral, Suspension, Capsule, extended release - Oral, Tablet - Oral, Tablet, Capsule, extended release, Injection, powder, for solution, Intravenous, Injection, powder, for solution - Intravenous, Tablet, chewable, Tablet, chewable - Oral, Solution, Solution - Oral

Bipolar Disorder

, 100.0 mg, 200.0 mg, 400.0 mg, 300.0 mg, 100.0 mg/mL, 20.0 mg/mL, 10.0 mg/mL

, Tablet, extended release - Oral, Tablet, extended release, Oral, Suspension - Oral, Suspension, Capsule, extended release - Oral, Tablet - Oral, Tablet, Capsule, extended release, Injection, powder, for solution, Intravenous, Injection, powder, for solution - Intravenous, Tablet, chewable, Tablet, chewable - Oral, Solution, Solution - Oral

Seizures

, 100.0 mg, 200.0 mg, 400.0 mg, 300.0 mg, 100.0 mg/mL, 20.0 mg/mL, 10.0 mg/mL

, Tablet, extended release - Oral, Tablet, extended release, Oral, Suspension - Oral, Suspension, Capsule, extended release - Oral, Tablet - Oral, Tablet, Capsule, extended release, Injection, powder, for solution, Intravenous, Injection, powder, for solution - Intravenous, Tablet, chewable, Tablet, chewable - Oral, Solution, Solution - Oral

Warnings

Epitol has six contraindications, and should be avoided when experiencing the conditions listed in the following table.

Epitol Contraindications

Condition

Risk Level

Notes

Pulse Frequency

Do Not Combine

Pulse Frequency

Do Not Combine

Pulse Frequency

Do Not Combine

Pulse Frequency

Do Not Combine

Bone Marrow

Do Not Combine

Severe Hypersensitivity Reactions

Do Not Combine

Carbamazepine may interact with Pulse Frequency

There are 20 known major drug interactions with Epitol.

Common Epitol Drug Interactions

Drug Name

Risk Level

Description

1,2-Benzodiazepine

Major

The metabolism of 1,2-Benzodiazepine can be increased when combined with Carbamazepine.

2-Methoxyethanol

Major

The risk or severity of adverse effects can be increased when Carbamazepine is combined with 2-Methoxyethanol.

3,5-diiodothyropropionic acid

Major

The metabolism of 3,5-diiodothyropropionic acid can be increased when combined with Carbamazepine.

5-androstenedione

Major

The metabolism of 5-androstenedione can be increased when combined with Carbamazepine.

7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline

Major

The risk or severity of adverse effects can be increased when Carbamazepine is combined with 7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline.

Epitol Toxicity & Overdose Risk

The lowest toxic dose of carbamazepine for women is 1920 mg/kg/17W and 54 mg/kg/9D for men. Signs of overdose usually appear 1-3 hours after ingestion and can include rapid heartbeat, high or low blood pressure, twitching muscles, dilated pupils, vomiting, confusion, and difficulty breathing. If you suspect someone has overdosed on carbamazepine, contact the local poison control center and provide supportive treatment. Make sure to monitor their vital signs and keep their airway open. It is also important to consider the potential for overdose due to taking multiple drugs.

Epitol Novel Uses: Which Conditions Have a Clinical Trial Featuring Epitol?

179 active clinical trials are in progress to assess the potential of Epitol in managing Partial Seizures With Secondary Generalization, Trigeminal Neuralgia and Restless Legs Syndrome (RLS).

Condition

Clinical Trials

Trial Phases

Chronic Pain

116 Actively Recruiting

Not Applicable, Phase 2, Phase 4, Phase 3, Early Phase 1, Phase 1

Bipolar Disorder

0 Actively Recruiting

Seizures

0 Actively Recruiting

Restless Legs Syndrome

3 Actively Recruiting

Not Applicable

Bipolar Disorder

0 Actively Recruiting

Seizures

4 Actively Recruiting

Phase 3, Phase 2, Phase 1

Trigeminal Neuralgia

0 Actively Recruiting

Syndrome

4 Actively Recruiting

Phase 2, Phase 3, Not Applicable

Common Cold

0 Actively Recruiting

Epitol Reviews: What are patients saying about Epitol?

5

Patient Review

10/17/2010

Epitol for Facial Nerve Pain

5

Patient Review

2/9/2011

Epitol for Bipolar Disorder in Remission

5

Patient Review

2/19/2011

Epitol for Convulsive Seizures

I found this medication made me feel very out of it and not at all like myself. It also caused some really strange side effects that were, in my opinion, worse than the issue I was taking it for.

5

Patient Review

7/3/2013

Epitol for Facial Nerve Pain

The dosage of 200mg made me feel drowsy and unfocused. I also felt pretty anxious while taking this.

4.7

Patient Review

12/25/2012

Epitol for Bipolar I Disorder with Most Recent Episode Mixed

I was on epitol for six months and it made me feel nauseous the whole time. I also had non-stop sneezing, watery eyes, and heartburn. Thankfully, I was recently taken off the medication and I feel so much better now. No more discomfort and I can breathe through my nose again!

4.7

Patient Review

2/18/2014

Epitol for Facial Nerve Pain

I'm pretty indifferent to this drug. I take it regularly and mostly I just zone out. My hearing is abnormal (under-toned) about half an hour after ingestion... which is really strange.

4.7

Patient Review

1/28/2013

Epitol for Facial Nerve Pain

This wasn't effective for me in terms of treating my tinnitus.

4.3

Patient Review

6/20/2012

Epitol for Facial Nerve Pain

Before I started taking this medicine, I was struggling with bipolar disorder to the point where I lost my job and was in danger of losing my family. But since starting this medication, I've been doing much better. We're a happy family again thanks to this treatment.

4

Patient Review

10/6/2012

Epitol for Facial Nerve Pain

I've had a lot of the rare but serious side effects. I'm only 25 and have experienced extreme headaches, joint pain, and flu-like symptoms. I've been on the medication for a month now and have to get off of it because it's making me so calm that I don't care about going out.

4

Patient Review

11/26/2012

Epitol for Nerve Pain

I had really severe trigeminal neuralgia, but this medication completely numbed the pain. I've needed to increase the dosage over time, though.

3.3

Patient Review

10/16/2011

Epitol for Bipolar I Disorder with Most Recent Episode Mixed

I experienced great results for the first two weeks, and then suddenly got a severe rash all over my body. Be careful when taking this medication and pay attention to any changes in your body.

3.3

Patient Review

10/14/2010

Epitol for Bipolar I Disorder with Most Recent Episode Mixed

3

Patient Review

11/18/2012

Epitol for Facial Nerve Pain

This drug unfortunately did not relieve any of my nerve pain symptoms. If anything, it made me feel more anxious.

2

Patient Review

3/14/2012

Epitol for Nerve Pain

I've used this treatment for five years with a lot of success, but now the pain is coming back.

1.3

Patient Review

8/3/2012

Epitol for Bipolar Disorder in Remission

I've been on this medication for four years and it's the only one that has worked to keep me seizure-free. I don't experience any side effects, though I only take one pill per day instead of the recommended dosage. My doctors are always telling me I need to up my intake, but so far so good!

1

Patient Review

3/3/2014

Epitol for Convulsive Seizures

After taking this drug, I experienced blurred vision and muscle loss in my legs.

1

Patient Review

6/6/2010

Epitol for Manic-Depression

image of drug pills surrounding a glass of water symbolizing drug consumption

Patient Q&A Section about epitol

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is Epitol the same as carbamazepine?

"Carbamazepine is an anticonvulsant and analgesic that is indicated to treat partial seizures with complex symptomatology (psychomotor, temporal lobe), generalized tonic-clonic seizures (grand mal), and mixed seizure patterns which include the above, or other partial or generalized seizures."

Answered by AI

What is Epitol used for?

"This medication is an anticonvulsant, which means it is used to prevent seizures. It is also used to relieve certain types of nerve pain, such as trigeminal neuralgia. This medication works by reducing the spread of seizure activity in the brain and restoring the normal balance of nerve activity."

Answered by AI

What are the side effects of Epitol?

"There are a few potential side effects associated with this medication including dizziness, drowsiness, constipation, dry mouth, unsteadiness, nausea, and vomiting."

Answered by AI

Clinical Trials for Epitol

Image of Alberta Children's Hospital in Calgary, Canada.

Therapeutic Cuddling for Pain in Critically Ill Children

< 65
All Sexes
Calgary, Canada

2.1 CONTEXT Pain and agitation are common comorbidities of pediatric critical illness due to both underlying disease processes and ICU related therapies. These are associated with both short and long term negative sequelae including increased mortality, length of stay, rates of ICU delirium, worse sleep, increased anxiety, depression, and chronic pain. The current standard of care to manage PICU associated pain and agitation is the use of analgosedation (e.g. opioids and benzodiazepines) these too are associated with increased time on the ventilator, length of stay, ICU delirium, and long term mental health and negative neuro-cognitive outcomes. Despite recommendations for increased use of non-pharmacologic therapies in the prevention and management of PICU associated pain, agitation, delirium, and analgosedation exposure, there are currently know therapies with clear evidence of efficacy. Therapeutic cuddling (e.g. kangaroo care, clothed cuddling, comfort holding, etc.) has been shown to decrease pain and anxiety in critically ill neonates, and healthy children and adults. Positive affective touch and hugging has known physiologic benefits and has been associated with decreased pain, improved immunity, and decreased mortality. Despite the potential for this intervention to aid in the prevention and management of PICU associated pain, agitation, delirium and analgosedation exposure, little data exists on efficacy of therapeutic cuddling in critically ill children. 2.2 OBJECTIVES 2.2.1 Primary Determine the feasibility of screening, consent, randomization, and retention of participants in a pragmatic RCT of therapeutic cuddling versus standard of care in the Alberta Children's Hospital Pediatric Intensive Care Unit. 2.2.2 Secondary 1. Determine treatment fidelity of participants randomized to the intervention arm. 2. Determine the prevalence of the therapeutic cuddling intervention in those randomized to the standard of care arm. 3. Determine the feasibility of measurement of key outcomes and co-variates (i.e., pain, agitation, sedation, delirium, analgosedation exposure, parental presence). 4. Describe the experience of patients, caregivers, and healthcare professionals in delivering/receiving the therapeutic cuddling intervention. 2.3 STUDY DESIGN Pilot feasibility randomized controlled trial of a structured co-designed therapeutic cuddling intervention as compared to the standard of care in a single tertiary care PICU. 2.4 DURATION 6 months to 1 year 2.5 LOCATION, DEPARTMENTS, AND FACILITY WHERE RESEARCH WILL BE UNDERTAKEN The pediatric intensive care unit at the Alberta Children's Hospital 2.6 SAMPLE SIZE A total sample size of 112 participants (56 per arm)

Recruiting
Has No Placebo

Alberta Children's Hospital

Have you considered Epitol clinical trials?

We made a collection of clinical trials featuring Epitol, we think they might fit your search criteria.
Go to Trials
Image of Donald Berman Maimonides Maimonides Geriatric Centre in Montreal, Canada.

Virtual Reality for Pain

Any Age
All Sexes
Montreal, Canada

This study will test whether immersive virtual reality (iVR) can reduce pain and discomfort during wound care for residents living in long-term care (LTC). Pressure ulcers are common and painful among older adults, and dressing changes often cause additional distress. Up to 20 residents at the Donald Berman Maimonides Geriatric Centre will use virtual reality headsets during routine wound care. The headsets display calm, low-stimulus scenes (e.g., puppies in a meadow) designed to distract and comfort participants. Each participant will take part for six weeks in three phases: * Two weeks of usual wound care (baseline) * Two weeks using virtual reality during wound care (intervention) * Two weeks of usual care again (washout) Pain will be assessed using validated tools, and the research team will also observe agitation, mood, and other behavioral indicators. Nursing staff will provide feedback on feasibility and acceptability of iVR use in LTC settings.

Recruiting
Has No Placebo

Donald Berman Maimonides Maimonides Geriatric Centre

Machelle Wilchesky, PhD

Image of Cincinnati Urogynecology Associates in Cincinnati, United States.

Nitrous Oxide for Pain During Bladder Botox Injections

18+
Female
Cincinnati, OH

The goal of this clinical trial is to assess if a mix of nitrous oxide and oxygen can improve pain control during bladder Botox injections. The primary question it aims to answer is: Does using nitrous oxide lower the overall level of pain during the procedure? Researchers will compare a 50:50 nitrous oxide/oxygen mixture (administered with the Pro-Nox system) plus standard care (with lidocaine in the bladder) to sham mask plus standard care to see if nitrous oxide works better for lowering pain. Participants will: * Receive their bladder Botox injection in the office setting * Either use nitrous oxide/oxygen plus standard care during the procedure, or sham mask plus standard care * Answer brief questions about pain, anxiety, satisfaction, and willingness to repeat the procedure

Phase 4
Waitlist Available

Cincinnati Urogynecology Associates (+1 Sites)

Have you considered Epitol clinical trials?

We made a collection of clinical trials featuring Epitol, we think they might fit your search criteria.
Go to Trials

Have you considered Epitol clinical trials?

We made a collection of clinical trials featuring Epitol, we think they might fit your search criteria.
Go to Trials